SSStine Hedegaard Scheuer

Stine Hedegaard Scheuer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stine Hedegaard Scheuer has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PIONEER REAL Spain : A multicentre, prospective, real‐world study of oral semaglutide use in adults with type 2 diabetes

    by Elías Delgado Álvarez, Cristóbal Morales Portillo, Cristina Abreu Padín, Alberto Aliaga Verdugo, Ana Piera Carbonell, Aída Cadenas González, Jaime Amor Valero, Verónica González López, Christina Louise Rasmussen, Stine Hedegaard Scheuer, et al.

    Aims: This study evaluated clinical outcomes of oral semaglutide treatment in adults with type 2 diabetes (T2D) in a real‐world setting in Spain as part of the 13‐country PIONEER REAL programme. Materials and Methods: This multicentre, prospective, non‐interventional, single‐arm study (NCT05443334) followed participants for 34–44 weeks. Participants were treated as part of routine clinical practice and were naïve to injectable glucose‐lowering medication. The primary endpoint was the change in glycated haemoglobin (HbA 1c ) from baseline to end of study (EOS). Secondary endpoints included changes in body weight, the proportion of participants with HbA 1c 1c was −1.4%‐points (95%CI −1.5, −1.3; p < 0.0001) and in body weight −6.8% (95%CI −7.4, −6.1; p < 0.0001). In participants using SGLT2is, change in HbA 1c was −1.8%‐points (95%CI −2.1, −1.6; p < 0.0001) versus −1.2%‐points (95%CI −1.3, −1.1; p < 0.0001) in participants without SGLT2is. HbA 1c change was −1.4%‐points (95%CI −1.6, −1.3; p < 0.0001) in participants with T2D duration ≤5 years versus −1.2%‐points (95%CI −1.3, −1.0; p < 0.0001) with T2D duration >5 years. At EOS, 77.4% of participants achieved an HbA 1c level 1c and ≥5% body weight reduction. Treatment satisfaction increased, and no new safety concerns were identified. Conclusions: Oral semaglutide treatment improved glycaemic control and reduced body weight in Spanish clinical practice. Early intervention and SGLT2i co‐treatment were associated with more favourable outcomes.


  • Open Access

    Time trends in life expectancy of people with severe mental illness in Scotland, 2000–2019: population-based study

    by Kelly J. Fleetwood, Raied Alotaibi, Stine H. Scheuer, Daniel J. Smith, Sarah H. Wild, Caroline A. Jackson

    Background: People with severe mental illness (SMI) have a higher risk of premature mortality than the general population. Aims: To investigate whether the life expectancy gap for people with SMI is widening, by determining time trends in excess life-years lost. Method: This population-based study included people with SMI (schizophrenia, bipolar disorder and major depression) alive on 1 January 2000. We ascertained SMI from psychiatric hospital admission records (1981–2019), and deaths via linkage to the national death register (2000–2019). We used the Life Years Lost (LYL) method to estimate LYL by SMI and sex, compared LYL to the Scottish population and assessed trends over 18 3-year rolling periods. Results: We included 28 797 people with schizophrenia, 16 657 with bipolar disorder and 72 504 with major depression. Between 2000 and 2019, life expectancy increased in the Scottish population but the gap widened for people with schizophrenia. For 2000–2002, men and women with schizophrenia lost an excess 9.4 (95% CI 8.5–10.3) and 8.2 (95% CI 7.4–9.0) life-years, respectively, compared with the general population. In 2017–2019, this increased to 11.8 (95% CI 10.9–12.7) and 11.1 (95% CI 10.0–12.1). The life expectancy gap was lower for bipolar disorder and depression and unchanged over time. Conclusions: The life expectancy gap in people with SMI persisted or widened from 2000 to 2019. Addressing this entrenched disparity requires equitable social, economic and health policies, healthcare re-structure and improved resourcing, and investment in interventions for primary and secondary prevention of SMI and associated comorbidities.


  • Open Access

    Time-trends in life expectancy of people with severe mental illness in Scotland, 2000-2019: a population-based study

    by Kelly Fleetwood, Raied Alotaibi, Stine H Scheuer, Daniel J Smith, Sarah H Wild, Caroline A Jackson

    Objective To determine time-trends in life expectancy (LE) of people with a severe mental illness (SMI) compared with the general population. Design Observational population-based study. Setting Scotland, 2000-2019. Linked psychiatric hospital admission and death records. Participants Adults with a psychiatric hospital admission record for schizophrenia (28,797), bipolar disorder (16,657) or major depression (72,504) compared with the Scottish population (4.3 million adults in 2011). Main outcome measures Trends over time in life years lost for people with schizophrenia, bipolar disorder or major depression compared with the Scottish population, for all deaths, and natural and unnatural deaths, stratified by sex. Results Among people with SMI, one third died during the study period. Between 2000 and 2019, LE increased in the general Scottish population and the LE gap widened for people with schizophrenia. For 2000-2002, men and women with schizophrenia lost an excess 9.4 (95% CI 8.5 to 10.3) and 8.2 (7.4 to 9.0) life years, respectively, compared to the general population. In 2017-2019, this excess life years lost increased to 11.8 (10.9 to 12.7) and 11.1 (10.0 to 12.1) for men and women, respectively. There was no evidence of a change over time in the LE gap of 5 to 8 years for people with bipolar disorder or major depression. Changes in LE for natural and unnatural causes of death varied by individual SMI and sex. Conclusions The LE gap in people with an SMI persisted or widened in Scotland from 2000-2019. These entrenched disparities reflect intersecting inequalities requiring coordinated solutions at multiple levels to improve LE in this and other marginalised and socially excluded groups. What is already known on this topic People with a severe mental illness (SMI) such as schizophrenia, bipolar disorder or major depression have a lower life expectancy (LE) than people without these conditions This gap is largely due to natural causes, particularly cardiovascular disease LE has increased for the general population but it is unclear whether the gaps in life expectancy for people with SMI have changed over time within the UK What this study adds The LE gap widened in people with schizophrenia and persisted for those with bipolar disorder and major depression in Scotland between 2000 and 2019 These findings reflect entrenched disparities in the LE of people with SMI Multi-level and synergistic solutions are needed to address these disparities

  • Open Access

    Ethnic disparities in quality of diabetes care in Scotland: A national cohort study

    by Stine H. Scheuer, Kelly Fleetwood, Sarah H. Wild, Caroline A. Jackson, Scottish Diabetes Research Network epidemiology group

    Aims: The aim of this study is to compare quality of diabetes care in people with type 2 diabetes by ethnicity, in Scotland.Methods: Using a linked national diabetes registry, we included 162,122 people newly diagnosed with type 2 diabetes between 2009 and 2018. We compared receipt of nine guideline indicated processes of care in the first‐year post‐diabetes diagnosis using logistic regression, comparing eight ethnicity groups to the White group. We compared annual receipt of HbA1c and eye screening during the entire follow‐up using generalised linear mixed effects. All analyses adjusted for confounders.Results: Receipt of diabetes care was lower in other ethnic groups compared to White people in the first‐year post‐diagnosis. Differences were most pronounced for people in the: African, Caribbean or Black; Indian; and other ethnicity groups for almost all processes of care. For example, compared to White people, odds of HbA1c monitoring were: 44% lower in African, Caribbean or Black people (OR 0.56 [95% CI 0.48, 0.66]); 47% lower in Indian people (OR 0.53 [95% CI 0.47, 0.61]); and 50% lower in people in the other ethnicity group (OR 0.50 [95% CI 0.46, 0.58]). Odds of receipt of eye screening were 30%–40% lower in most ethnic groups compared to the White group. During median 5 year follow‐up, differences in HbA1c monitoring and eye screening largely persisted, but attenuated slightly for the former.Conclusions: There are marked ethnic disparities in routine diabetes care in Scotland in the short‐ and medium‐term following diabetes diagnosis. Further investigation is needed to establish and effectively address the underlying reasons.


  • Trends in Incidence of Hospitalization for Hypoglycemia and Diabetic Ketoacidosis in Individuals With Type 1 or Type 2 Diabetes With and Without Severe Mental Illness in Denmark From 1996 to 2020: A Nationwide Study

    by Stine H. Scheuer, Gregers S. Andersen, Bendix Carstensen, Lars Diaz, Vanja Kosjerina, Nanna Lindekilde, Sarah H. Wild, Caroline A. Jackson, Frans Pouwer, Michael E. Benros, et al.

    OBJECTIVE: To examine trends in incidence of acute diabetes complications in individuals with type 1 or type 2 diabetes with and without severe mental illness (SMI) in Denmark by age and calendar year. RESEARCH DESIGN AND METHODS: We conducted a cohort study using nationwide registers from 1996 to 2020 to identify individuals with diabetes, ascertain SMI status (namely, schizophrenia, bipolar disorder, or major depression) and identify the outcomes: hospitalization for hypoglycemia and diabetic ketoacidosis (DKA). We used Poisson regression to estimate incidence rates (IRs) and incidence rate ratios (IRRs) of recurrent hypoglycemia and DKA events by SMI, age, and calendar year, accounting for sex, diabetes duration, education, and country of origin. RESULTS: Among 433,609 individuals with diabetes, 8% had SMI. Risk of (first and subsequent) hypoglycemia events was higher for individuals with SMI than for those without SMI (for first hypoglycemia event, IRR: type 1 diabetes, 1.77 [95% CI 1.56–2.00]; type 2 diabetes, 1.64 [95% CI 1.55–1.74]). Individuals with schizophrenia were particularly at risk for recurrent hypoglycemia events. The risk of first DKA event was higher in individuals with SMI (for first DKA event, IRR: type 1 diabetes, 1.78 [95% CI 1.50–2.11]; type 2 diabetes, 1.85 [95% CI 1.64–2.09]). Except for DKA in the type 2 diabetes group, IR differences between individuals with and without SMI were highest in younger individuals (<50 years old) but stable across the calendar year. CONCLUSIONS: SMI is an important risk factor for acute diabetes complication and effective prevention is needed in this population, especially among the younger population and those with schizophrenia.


  • Open Access

    Type 2 Diabetes Risk After Gestational Diabetes According to Country/Region of Origin: A Nationwide Register-based Study

    by Helene Nielsen, Anne Windolf-Nielsen, Stine H Scheuer, Peter Damm, Anne-Marie Nybo Andersen, Gregers Stig Andersen, Karoline Kragelund Nielsen

    Context: The risk of gestational diabetes mellitus (GDM) differs between the Danish population and several migrant groups. However, it is unclear if the incidence and timing of type 2 diabetes mellitus (T2DM) following GDM vary similarly. Objective: This work aimed to investigate the incidence of T2DM according to migration background based on country/region of origin among women with a previous GDM diagnosis and to explore the role of time since GDM diagnosis on the association. Method: Using nationwide registry data, we followed women diagnosed with GDM in Denmark during 2004 to 2018 to December 31, 2020. Poisson regression models were used to estimate incidence rates (IRs) of T2DM according to country/region of origin, adjusted for age, education, and body mass index. Results: The study included 20 873 women with a GDM diagnosis, of whom 22.3% were of migrant background and 77.7% were Danish. The mean follow-up time was 7.3 years, and 10.9% were registered with T2DM during the study period. Generally, migrant women had higher IRs of T2DM compared to Danish women, with substantial variations in risk between migrant groups. Women from Pakistan and Sri Lanka had 3 to 4 times higher IRs compared to Danish women. The timing of T2DM onset also varied, with women from Sri Lanka and Pakistan having an earlier onset of T2DM compared to other migrant and Danish women. Conclusion: This study demonstrated that country/region of origin is an important risk factor for T2DM in women with GDM. These findings underscore the importance of prevention programs targeting women with GDM and a high-risk origin.


  • Open Access

    Elevated risk of developing type 2 diabetes in people with a psychiatric disorder: What is the role of health behaviors and psychotropic medication?

    by Nanna Lindekilde, Lars J. Diaz, Mathias Lasgaard, Jan Erik Henriksen, Stine H. Scheuer, Gregers S. Andersen, Katrine H. Rubin, Frans Pouwer


  • Open Access

    Indicators of quality of diabetes care in persons with type 2 diabetes with and without severe mental illness: a Danish nationwide register-based cohort study

    by Lenette Knudsen, Stine H. Scheuer, Lars J. Diaz, Caroline A. Jackson, Sarah H. Wild, Michael E. Benros, Dorte L. Hansen, Marit E. Jørgensen, Gregers S. Andersen


  • P32 Quality of diabetes care in people with and without prior hospitalisation for serious mental illness: a retrospective national cohort study

    by Caroline Jackson, Stine Scheuer, Kelly Fleetwood, Kirsty Licence, Stewart Mercer, Daniel Smith, Cathie Sudlow, Gregers Anderson, Sarah Wild

    Background Among people with type 2 diabetes (T2D), those with comorbid serious mental illness (SMI) are at increased risk of diabetes complications and early death, which could be related to quality of diabetes care. We therefore sought to compare the receipt of diabetes care in people with and without SMI in the first year after T2D diagnosis and in the longer term. Methods Using national Scottish population-based records, we included 119,508 people with T2D diagnosed from 2009 – 2018 and ascertained those with a prior hospital record of schizophrenia, bipolar disorder, or depression. The outcomes were annual assessment of each of HbA1c, cholesterol, urinary albumin, serum creatinine, blood pressure, retinopathy screening, foot examination, body mass index, smoking status, and overall care (having received all measures). We compared receipt of each measure in the first year after diabetes diagnosis in people with and without each SMI using logistic regression. We then compared receipt of HbA1c (a marker of measures routinely measured in the primary care setting) and retinopathy every year post diagnosis to end of follow-up (31.12.2018) using generalized linear mixed effect models. Analyses were adjusted for age, sex, calendar year, diabetes duration, area-based deprivation, ethnicity, urbanicity, health board, smoking and history of alcohol disorder, CVD, and other comorbidities. Results People with SMI (n=7,680) were more likely to: be younger; be white; live in deprived areas; have a history of alcohol use disorder, CVD, and comorbidities; and be smokers. Compared to people without a SMI those with schizophrenia, bipolar disorder and depression had a lower odds of receiving urinary albumin tests, retinopathy screenings and overall care and a higher odds of receiving cholesterol and serum creatinine measurements in the first year after diabetes diagnosis. Receipt of the other measurements were similar in each group. In the longitudinal analysis, receipt of retinopathy remained lower in those with versus without each SMI, but there was no difference in receipt of HbA1c. Conclusion Receipt of most processes of care was similar in people with and without SMI during the first year post-diabetes diagnosis and in the longer term. However, people with SMI were less likely to have urinary albumin checked and retinopathy screening. This indicates that there is scope to improve receipt of these diabetes monitoring measures among people with SMI.

  • Open Access

    Severe Mental Illness and the Risk of Diabetes Complications: A Nationwide, Register-based Cohort Study

    by Stine H Scheuer, Vanja Kosjerina, Nanna Lindekilde, Frans Pouwer, Bendix Carstensen, Marit E Jørgensen, Michael E Benros, Gregers S Andersen

    Context: Individuals with severe mental illness (SMI) are at increased risk of developing type 2 diabetes. Objective: This work explores whether individuals with diabetes and SMI are also at increased risk of diabetes complications and the potential age-specific differences in development of these. Methods: Using nationwide registry data, we followed the entire Danish population with type 2 diabetes from January 1, 1996 to December 31, 2018. Exposure was SMI (schizophrenia, bipolar, or depression disorders). Outcome was diabetes complications (nephropathy, retinopathy, lower limp amputations, and cardiovascular disease). We applied Poisson regression models to estimate overall incidence rate ratios (IRRs) and age-specific incidence rates (IRs) and IRRs of the first event of each complication in individuals with SMI compared to individuals without SMI. The models were adjusted for sex, age, diabetes duration, calendar year, education, and migration status. Results: We followed 371 625 individuals with type 2 diabetes, of whom 30 102 had coexisting diagnosed SMI. Individuals with SMI had a higher IR of nephropathy (IRR: 1.15; 95% CI, 1.12-1.18), amputations (IRR: 1.15; 95% CI, 1.04-1.28), and cardiovascular disease (men: IRR: 1.10; 95% CI, 1.05-1.15, women: IRR: 1.18; 95% CI, 1.13-1.22) but a lower IR of retinopathy (IRR: 0.75; 95% CI, 0.70-0.81) when compared to individuals without SMI, after adjustment for confounders. For all complications except amputations, the difference in IR was highest in the younger age groups. Conclusion: Individuals with type 2 diabetes and SMI had a higher risk and an earlier onset of several diabetes complications diagnoses, emphasizing focusing on improving diabetes management in younger age groups with SMI.